Dr Paxton Loke
Honorary (Senior Fellow)
Department of Paediatrics
76 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program
DOI: 10.1111/cea.701772026
Journal article
Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children
DOI: 10.1001/jamanetworkopen.2026.24102026
Journal article
The TreEat Study: a randomised controlled trial investigating the efficacy and safety of early introduction of tree nuts on the prevention of tree nut allergy in infants with peanut allergy
DOI: 10.1016/j.jaci.2025.12.9212026
Journal article
Correlation and Agreement Between Parent-Report and Self-Report Food Allergy Quality of Life Questionnaires After Oral Immunotherapy
DOI: 10.1111/cea.703522025
Journal article
Impact of Participant Baseline Factors on Exposure-Adjusted Incidence of Treatment-Related Adverse Events During Peanut Oral Immunotherapy
DOI: 10.1016/j.jaip.2025.09.0102025
Journal article
Probiotic oral immunotherapy for egg and milk allergy induces sustained unresponsiveness
DOI: 10.1111/pai.702222025
Journal article
Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy
DOI: 10.1111/pai.70177
RECENT SCHOLARLY WORKS
2025
Journal article
The Conversation on Oral Immunotherapy for Preschool Children Must Continue
DOI: 10.1111/cea.700272025
Journal article
Cost-Effectiveness of Oral Immunotherapy for Egg Allergy According to Age of Therapy Commencement
DOI: 10.1016/j.jaip.2024.12.0052025
Journal article
Allergen-Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
DOI: 10.1111/all.16451